Tumor DNA sequencing confirmed the presence of a canonical IDH1 mutation (c.395G > A p.R132H, VAF32%) and identified two TP53 variants (c.747G > T p.R249S, VAF 17%; c.993 + 1G > A, VAF 8.41%). The gene discussed is IDH1; the disease is neoplasm.